Spyglass Pharma, Inc. · NASDAQ:SGP
Ra Capital Management, L.P. reported a 24.10% stake in Spyglass Pharma, Inc. (Schedule 13D)
Event Feb 9, 2026 · Filed Feb 17, 2026
Ra Capital Management, L.P. reported a 24.10% stake in Spyglass Pharma, Inc., 8,022,639 shares, with active intent on Feb 9, 2026. Filed Feb 17, 2026 (Schedule 13D).
- Stake
- 24.10%
- Shares
- 8,022,639
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 24.10% | 8,022,639 |
| Peter Kolchinsky | 24.10% | 8,022,639 |
| Rajeev Shah | 24.10% | 8,022,639 |
| RA Capital Healthcare Fund, L.P. | 17.90% | 5,966,439 |
| RA Capital Nexus Fund III, L.P. | 6.20% | 2,054,678 |
Source
Related
- Spyglass Pharma, Inc.
- Ra Capital Management, L.P.
- Spyglass Pharma, Inc. shareholders
- Schedule 13G · Srinivas Akkaraju · Feb 17, 2026
- Schedule 13D · New Enterprise Associates 17, L.P. · Feb 13, 2026
- Schedule 13D · Gilde Healthcare Holding B.V. · Feb 13, 2026
- Schedule 13G · Sands Frank M. · Feb 13, 2026
- Schedule 13D · Vensana Capital I GP, LLC · Feb 10, 2026